# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sonny Liston (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX007-SYN
- Date: 2026-06-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Malcolm Achebe-Whitford, MD
- Calendar frame: modern shifted

## What we are working on

- He wants to keep fighting and needs his blood pressure under control to pass the commission physical **S**
- He wants things explained to him out loud, not handed to him on paper **S**
- He knows he drinks too much between fights and wants to cut down without being lectured **S**

## Your goals

- Confirm or rule out hypertension with out-of-office readings before any medicine. Target: 2026-06-23. Recorded outcome: Ambulatory monitoring confirmed stage 2 hypertension (daytime 146/94 mmHg). **S**
- Blood pressure under 130/80 mmHg in the clinic and at home by four months. Target: 2026-10-20. Recorded outcome: Clinic 122/76 mmHg; home average 120/76 mmHg on amlodipine 10 mg and valsartan 160 mg. **S**
- Drink within the goal he set: no more than 14 drinks a week and no more than 4 on any day, and none in the two weeks before a fight. Target: 2026-10-20. Recorded outcome: About 8 drinks a week with no day above 3; AUDIT 7; GGT normal. **S**
- Explain his medicines and blood pressure plan back in his own words. Target: 2026-07-21. Recorded outcome: Teach-back correct at four weeks with the picture card. **S**

## What we agreed to do

- Confirm the blood pressure out of the office with 24-hour ambulatory monitoring before any diagnosis or medicine; baseline metabolic panel, glucose, lipids, urine albumin, TSH and ECG. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); Hypertension in Adults: Screening (2021); CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026) **S**
- Cardiology consultation on the same day as the two-week visit: confirm and stage the hypertension, echocardiogram, choice of treatment, and fitness to compete. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (Black HR, et al.) (2015) **S**
- Alcohol: nonjudgmental brief intervention with motivational interviewing; a drinking goal he sets himself; medicines (naltrexone, acamprosate or topiramate) explained; AUDIT-C at each follow-up and liver tests. Guideline: The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018) **S**
- Safety plan given out loud and as a picture card, with the 988 Suicide & Crisis Lifeline saved in his phone as a voice contact; safety reviewed at every visit. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Health literacy universal precautions at every visit: plain spoken explanations, one or two key points at a time, teach-back, a picture-based medicine and blood pressure card, consent forms read aloud with time for questions, phone and voice-message reminders instead of letters, and an adult literacy program offered without pressure. Guideline: AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024) **S**
- Trauma-informed care: an ACE-informed history in which he chooses what to share, explanation and permission before each part of the examination, a PTSD screen, and counseling offered. Guideline: Trauma-Informed Care in Behavioral Health Services (Treatment Improvement Protocol 57) (2014); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023) **S**
- Drug use screening with the DAST-10; naloxone and overdose education if any opioid use is reported or suspected. Guideline: Unhealthy Drug Use: Screening (2020); Opioid Overdose Reversal Medications (2026) **S**
- Start a single-pill combination of amlodipine 5 mg and valsartan 160 mg each morning for stage 2 hypertension; potassium and creatinine in two to four weeks; home blood pressure with a talking, large-display monitor; lower-salt eating and alcohol reduction. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026) **S**
- Competing: no bouts until blood pressure is controlled, then clearance by the commission physician with a repeat check; no stimulants, decongestants or weight-cut diuretics. Guideline: Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (Black HR, et al.) (2015) **S**
- Raise the combination to amlodipine 10 mg and valsartan 160 mg; start naltrexone 50 mg each morning, with a wallet card saying it blocks opioid pain medicines and a liver test recheck in two months. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018) **S**
- Cardiovascular risk and preventive care at the preventive visit: lipids, risk estimate, immunizations and one-time screenings. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026) **S**

## Follow-up

- 2026-06-09: Establishing care: a high blood pressure reading at a boxing commission check, trauma-informed history, alcohol and drug screening with a safety assessment, and health literacy **S**
- 2026-06-23: Two-week review, seen the same day by cardiology: ambulatory monitoring, echocardiogram, the diagnosis and treatment, and fitness to compete **S**
- 2026-07-21: Four-week review: blood pressure on treatment, potassium and creatinine, drinking, and medicine teach-back **S**
- 2026-08-11: Periodic adult preventive visit **S**
- 2026-09-22: Three-month review: blood pressure, liver tests and drinking on naltrexone **S**
- 2026-10-20: Four-month review: blood pressure at goal, AUDIT, and the plan ahead **S**

This teaching document does not replace care from a qualified clinician.
